Junliang Pan
7Patents
2h-index
22Co-inventors
51Inventor score
Filing activity: Aug 20, 1993 → Jul 28, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8481030B2 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | Chemistry; Metallurgy | 7 | Active |
| US5605821A | Expression control sequences of the P-selectin gene | Chemistry; Metallurgy | 3 | Expired |
| US9309324B2 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | Chemistry; Metallurgy | 2 | Active |
| US6692922B2 | Method for identifying agents which modulate chemokine “MEC”-induced functions of CCR3 | Human Necessities | 0 | Expired |
| US10035840B2 | Targeted coagulation factors and method of using the same | Chemistry; Metallurgy | 0 | Active |
| USRE47150E1 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | General | 0 | Active |
| US9422362B2 | Targeted coagulation factors and method of using the same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.